Business
DEVONIAN ANNOUNCES SHARE CONSOLIDATION IN FURTHER PREPARATION FOR POTENTIAL U.S. LISTING
DEVONIAN ANNOUNCES SHARE CONSOLIDATION IN FURTHER PREPARATION FOR POTENTIAL U.S. LISTING ...
About this update from Devonian Health Group, Inc.
[{"type":"text","content":"\n\n\nDEVONIAN ANNOUNCES SHARE CONSOLIDATION IN FURTHER PREPARATION FOR POTENTIAL U.S. LISTING\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\nCanada NewsWire\n\n\nQUÉBEC, Jan. 20, 2026 /CNW/ - Devonian Health Group Inc. (\"Devonian\" or the \"Company\") (TSXV: GSD) (OTCQB: DVHGF) is pleased to announce that, in connection with an evaluation of an additional listing of the Company's common shares (\"Common Shares\") on a U.S. stock exchange, following the approval of its shareholders by a majority of 99,79 %, the Company will be implementing a consolidation (reverse stock split) of its outstanding Common Shares on the basis of one new Common Share for every sixty currently outstanding Common Shares (the \"Consolidation Ratio\").\n\n\n\n\n\n\n\nThe Company believes that the increase to the trading price of the Common Shares from effecting the consolidation could potentially, and principally (i) broaden the pool of investors that may consider investing or be able to invest in the Company, and (ii) enable the Company to satisfy certain minimum trading price requirements of U.S. and other stock exchanges for a potential listing of the Common Shares.\nThe Consolidation Ratio was determined by the Company's board of directors and the officers of the Company in accordance with the parameters authorized by the Company's shareholders at the Company's annual and special meeting of the shareholders held on March 20, 2025. The consolidation is subject to final acceptance of the TSX Venture Exchange (the \"TSXV\"). The Company intends to complete the consolidation at the open of market on or around January 22, 2026 and the Common Shares are expected to commence trading on the TSXV on a post‑consolidation basis beginning at the open of markets on or around January 22, 2026, under the existing name and symbol \"GSD\". On the OTCQB Venture Market, the Company's trading symbol will also remain unchanged, although a \"D\" will be temporarily appended as the fifth character of the trading symbol for 20 business days starting the effective date of the consolidation....